We are live on ! Find out more
VCNX

Vaccinex, Inc. Common Stock
VCNX

Delisted

VCNX was delisted on the 17th of December, 2024.

Back to rankings

11 hedge funds and large institutions have $898K invested in Vaccinex, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

15% less funds holding

Funds holding: 13 → 11 (-2)

49% less capital invested

Capital invested by funds: $1.76M → $898K (-$864K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TI
Telemetry Investments
New York
+$18.3K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$14.7K
3
PAM
Panagora Asset Management
Massachusetts
+$8.55K
4
UBS Group
UBS Group
Switzerland
+$8.55K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$61.1K
2
Morgan Stanley
Morgan Stanley
New York
-$14.7K
3
TRCT
Tower Research Capital (TRC)
New York
-$13K
4
Northern Trust
Northern Trust
Illinois
-$8.55K
5
CCA
Catalyst Capital Advisors
New York
-$3K

VCNX Hedge Fund Activity: Q4 2018 in Review

11 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q4 2018, worth a combined $898K — down 49% from $1.76M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VCNX and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Telemetry Investments, adding an estimated $18.3K. The largest seller was Millennium Management, cutting an estimated $61.1K.

  • 11 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q4 2018, down from 13 in Q3 2018.
  • Funds reported $898K of Vaccinex, Inc. Common Stock stock for Q4 2018, down 49% quarter-over-quarter.
  • 1 fund opened new Vaccinex, Inc. Common Stock positions in Q4 2018 and 3 closed out, a net change of -2 holders.
  • The largest Vaccinex, Inc. Common Stock buyer in Q4 2018 was Telemetry Investments, an estimated $18.3K added.
  • The largest Vaccinex, Inc. Common Stock seller in Q4 2018 was Millennium Management, an estimated $61.1K sold.

Based on aggregated 13F filings for Q4 2018.